Below are the most recent publications written about "Fluoxetine" by people in Profiles.
-
Levy R, Mathai M, Chatterjee P, Ongeri L, Njuguna S, Onyango D, Akena D, Rota G, Otieno A, Neylan TC, Lukwata H, Kahn JG, Cohen CR, Bukusi D, Aarons GA, Burger R, Blum K, Nahum-Shani I, McCulloch CE, Meffert SM. Implementation research for public sector mental health care scale-up (SMART-DAPPER): a sequential multiple, assignment randomized trial (SMART) of non-specialist-delivered psychotherapy and/or medication for major depressive disorder and posttraumatic stress disorder (DAPPER) integrated with outpatient care clinics at a county hospital in Kenya. BMC Psychiatry. 2019 12 28; 19(1):424.
-
Bonin Pinto C, Morales-Quezada L, de Toledo Piza PV, Zeng D, Saleh Vélez FG, Ferreira IS, Lucena PH, Duarte D, Lopes F, El-Hagrassy MM, Rizzo LV, Camargo EC, Lin DJ, Mazwi N, Wang QM, Black-Schaffer R, Fregni F. Combining Fluoxetine and rTMS in Poststroke Motor Recovery: A Placebo-Controlled Double-Blind Randomized Phase 2 Clinical Trial. Neurorehabil Neural Repair. 2019 08; 33(8):643-655.
-
Nazzi S, Maddaloni G, Pratelli M, Pasqualetti M. Fluoxetine Induces Morphological Rearrangements of Serotonergic Fibers in the Hippocampus. ACS Chem Neurosci. 2019 07 17; 10(7):3218-3224.
-
Weaver SR, Xie C, Charles JF, Hernandez LL. In utero and lactational exposure to the Selective Serotonin Reuptake Inhibitor fluoxetine compromises pup bones at weaning. Sci Rep. 2019 01 18; 9(1):238.
-
Messacar K, Sillau S, Hopkins SE, Otten C, Wilson-Murphy M, Wong B, Santoro JD, Treister A, Bains HK, Torres A, Zabrocki L, Glanternik JR, Hurst AL, Martin JA, Schreiner T, Makhani N, DeBiasi RL, Kruer MC, Tremoulet AH, Van Haren K, Desai J, Benson LA, Gorman MP, Abzug MJ, Tyler KL, Dominguez SR. Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis. Neurology. 2019 04 30; 92(18):e2118-e2126.
-
Huang J, Liu X, Luo X, Tang C, Xu M, Wood L, Wang Y, Wang QM. Effects of Fluoxetine on Poststroke Dysphagia: A Clinical Retrospective Study. J Stroke Cerebrovasc Dis. 2018 Nov; 27(11):3320-3327.
-
Babb JA, Linnros SE, Commons KG. Evidence for intact 5-HT1A receptor-mediated feedback inhibition following sustained antidepressant treatment in a rat model of depression. Neuropharmacology. 2018 10; 141:139-147.
-
Weaver SR, Fricke HP, Xie C, Lipinski RJ, Vezina CM, Charles JF, Hernandez LL. Peripartum Fluoxetine Reduces Maternal Trabecular Bone After Weaning and Elevates Mammary Gland Serotonin and PTHrP. Endocrinology. 2018 08 01; 159(8):2850-2862.
-
Barone I, Melani R, Mainardi M, Scabia G, Scali M, Dattilo A, Ceccarini G, Vitti P, Santini F, Maffei L, Pizzorusso T, Maffei M. Fluoxetine Modulates the Activity of Hypothalamic POMC Neurons via mTOR Signaling. Mol Neurobiol. 2018 Dec; 55(12):9267-9279.
-
Park S, Kim JM, Shin W, Han SW, Jeon M, Jang HJ, Jang IS, Kang J. BTNET : boosted tree based gene regulatory network inference algorithm using time-course measurement data. BMC Syst Biol. 2018 03 19; 12(Suppl 2):20.